Digital Transformation in Pharma managing content and assets across the digital supply chain

Pulse, a specialist healthcare organisation, review how digital transformation has impacted how global life sciences and pharmaceutical organisations, and the way they reach and engage with healthcare professionals (HCP's). The change, empowered by digital and its associated technologies, is being driven both by patients and HCP's.

Spotlight

The iQ Group Global

The iQ Group Global provides a turnkey solution for life sciences companies, spanning corporate advisory and investment banking, through to research, development, commercialization and sales. The Group facilitates an end to end solution along the drug lifecycle creating the medicines of tomorrow. Our life science and pharmaceutical business unit collaborates with scientists the world over: identifying and owning Intellectual Property, creating and executing drug development plans from discovery to market. In addition, our dedicated investment banking business transforms biotech from an alternative investment option to a requisite mainstream capital market asset. We design and market innovative structured financial products and solutions. These provide entry and exit, investment and divestment, in the 12 or more-year drug development cycle. In this way, The iQ Group Global is bridging capital with science to create the medicines of the future.

OTHER VIDEOS

The Cardinal Health™ InteLogix™ Platform

video | September 6, 2023

Learn about the industry’s first pharmaceutical supply chain solution that is reducing the cost of care and ensuring access to critical medications for hospitals and health systems....

Watch Now

Aeris: Benchtop XRD for pharmaceutical solid form analysis

video | August 28, 2023

Is solid form characterization critical in your line of work, but you lack expertise in X-ray diffraction (XRD)? Do you need an efficient tool to support you with lead optimization? Do you need an easy way to validate the stability of your solid form following processing?...

Watch Now

Semi-automated testing of on-body delivery systems (OBDS)

video | August 17, 2023

Injection systems that are attached to the patient's body (on-body delivery system OBDS) minimize possible risks, that can occur when drugs are administered by conventional needle-based injection systems (NIS)....

Watch Now

Line Optimizer - digital guided workflows for optimized pharma production operations

video | May 26, 2023

Connectivity in general is becoming an ever more important consideration for production facilities as we endeavour to produce more with less and all the while trying to satisfy an increasing need for more information and communication to and from the production equipment itself....

Watch Now

Spotlight

The iQ Group Global

The iQ Group Global provides a turnkey solution for life sciences companies, spanning corporate advisory and investment banking, through to research, development, commercialization and sales. The Group facilitates an end to end solution along the drug lifecycle creating the medicines of tomorrow. Our life science and pharmaceutical business unit collaborates with scientists the world over: identifying and owning Intellectual Property, creating and executing drug development plans from discovery to market. In addition, our dedicated investment banking business transforms biotech from an alternative investment option to a requisite mainstream capital market asset. We design and market innovative structured financial products and solutions. These provide entry and exit, investment and divestment, in the 12 or more-year drug development cycle. In this way, The iQ Group Global is bridging capital with science to create the medicines of the future.

Events